Commercialisation Solutions News Today

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organisations, has been recognised with a number of prestigious business and industry awards in April 2022, including Company of the Year at the ...

Press release content from Business Wire. The AP news staff was not involved in its creation.